Cheng Zishuo, VanPelt Jamie, Bergstrom Alexander, Bethel Christopher, Katko Andrew, Miller Callie, Mason Kelly, Cumming Erin, Zhang Huan, Kimble Robert L, Fullington Sarah, Bretz Stacey Lowery, Nix Jay C, Bonomo Robert A, Tierney David L, Page Richard C, Crowder Michael W
Department of Chemistry and Biochemistry , Miami University , 651 East High Street, 160 Hughes Laboratories , Oxford , Ohio 45056 , United States.
Research Service , Louis Stokes Cleveland Department of Veterans Affairs Medical Center , Cleveland , Ohio 44106 , United States.
Biochemistry. 2018 Sep 4;57(35):5218-5229. doi: 10.1021/acs.biochem.8b00728. Epub 2018 Aug 21.
In an effort to evaluate whether a recently reported putative metallo-β-lactamase (MβL) contains a novel MβL active site, SPS-1 from Sediminispirochaeta smaragdinae was overexpressed, purified, and characterized using spectroscopic and crystallographic studies. Metal analyses demonstrate that recombinant SPS-1 binds nearly 2 equiv of Zn(II), and steady-state kinetic studies show that the enzyme hydrolyzes carbapenems and certain cephalosporins but not β-lactam substrates with bulky substituents at the 6/7 position. Spectroscopic studies of Co(II)-substituted SPS-1 suggest a novel metal center in SPS-1, with a reduced level of spin coupling between the metal ions and a novel Zn metal binding site. This site was confirmed with a crystal structure of the enzyme. The structure shows a Zn site that is similar to that in NDM-1 and other subclass B1 MβLs; however, the Zn metal ion is coordinated by two histidine residues and a water molecule, which is held in position by a hydrogen bond network. The Zn metal is displaced nearly 1 Å from the position reported in other MβLs. The structure also shows extended helices above the active site, which create a binding pocket that precludes the binding of substrates with large, bulky substituents at the 6/7 position of β-lactam antibiotics. This study reveals a novel metal binding site in MβLs and suggests that the targeting of metal binding sites in MβLs with inhibitors is now more challenging with the identification of this new MβL.
为了评估一种最近报道的假定金属β-内酰胺酶(MβL)是否含有新型MβL活性位点,对来自翠绿栖泥螺旋体的SPS-1进行了过表达、纯化,并使用光谱学和晶体学研究对其进行了表征。金属分析表明,重组SPS-1结合了近2当量的锌(II),稳态动力学研究表明,该酶可水解碳青霉烯类和某些头孢菌素,但不能水解在6/7位带有庞大取代基的β-内酰胺底物。对钴(II)取代的SPS-1进行的光谱学研究表明,SPS-1中存在一个新型金属中心,金属离子之间的自旋耦合水平降低,且存在一个新型锌金属结合位点。该位点通过酶的晶体结构得到了证实。该结构显示了一个与NDM-1和其他B1亚类MβL中类似的锌位点;然而,锌金属离子由两个组氨酸残基和一个水分子配位,该水分子通过氢键网络固定在位。锌金属相对于其他MβL中报道的位置偏移了近1 Å。该结构还显示了活性位点上方的延伸螺旋,形成了一个结合口袋,阻止了在β-内酰胺抗生素6/7位带有大的、庞大取代基的底物的结合。这项研究揭示了MβL中的一个新型金属结合位点,并表明随着这种新MβL的鉴定,用抑制剂靶向MβL中的金属结合位点现在更具挑战性。